EMD-17523
Cryo-EM structure of apo CAK
EMD-17523
Single-particle2.3 Å

Map released: 20/03/2024
Last modified: 27/03/2024
Sample Organism:
Homo sapiens
Sample: CDK-activating kinase
Raw data: EMPIAR-11800
Deposition Authors: Cushing VI
,
Koh AF
,
Feng J,
Jurgaityte K
,
Bahl AK,
Ali S
,
Kotecha A
,
Greber BJ
Sample: CDK-activating kinase
Raw data: EMPIAR-11800
Deposition Authors: Cushing VI






High-resolution cryo-EM of the human CDK-activating kinase for structure-based drug design.
Cushing VI
,
Koh AF
,
Feng J,
Jurgaityte K
,
Bondke A,
Kroll SHB,
Barbazanges M
,
Scheiper B,
Bahl AK,
Barrett AGM
,
Ali S
,
Kotecha A
,
Greber BJ
(2024) Nat Commun , 15 , 2265 - 2265








(2024) Nat Commun , 15 , 2265 - 2265
Abstract:
Rational design of next-generation therapeutics can be facilitated by high-resolution structures of drug targets bound to small-molecule inhibitors. However, application of structure-based methods to macromolecules refractory to crystallization has been hampered by the often-limiting resolution and throughput of cryogenic electron microscopy (cryo-EM). Here, we use high-resolution cryo-EM to determine structures of the CDK-activating kinase, a master regulator of cell growth and division, in its free and nucleotide-bound states and in complex with 15 inhibitors at up to 1.8 Å resolution. Our structures provide detailed insight into inhibitor interactions and networks of water molecules in the active site of cyclin-dependent kinase 7 and provide insights into the mechanisms contributing to inhibitor selectivity, thereby providing the basis for rational design of next-generation therapeutics. These results establish a methodological framework for the use of high-resolution cryo-EM in structure-based drug design.
Rational design of next-generation therapeutics can be facilitated by high-resolution structures of drug targets bound to small-molecule inhibitors. However, application of structure-based methods to macromolecules refractory to crystallization has been hampered by the often-limiting resolution and throughput of cryogenic electron microscopy (cryo-EM). Here, we use high-resolution cryo-EM to determine structures of the CDK-activating kinase, a master regulator of cell growth and division, in its free and nucleotide-bound states and in complex with 15 inhibitors at up to 1.8 Å resolution. Our structures provide detailed insight into inhibitor interactions and networks of water molecules in the active site of cyclin-dependent kinase 7 and provide insights into the mechanisms contributing to inhibitor selectivity, thereby providing the basis for rational design of next-generation therapeutics. These results establish a methodological framework for the use of high-resolution cryo-EM in structure-based drug design.